COVID-19 Therapeutics
COVID-19 Therapeutics
Referral Info For Patients & Providers
Effective 12/1/2022, Total Infusion is no longer administering Bebtelovimab due to the rapid surge in resistant Omicron subvariants.
Read FDA Statement
Effective 1/26/2023, Total Infusion is no longer administering EVUSHELD due to resistant Omicron subvariants.
Read FDA Statement
Limited Access Available
Requires 3 Day Consecutive Treatment
Same Day Testing and Oral Antivirals Coming Soon!
ADDRESS:
Eastmont Town Center 6955 Foothill Blvd, Suite 67A, Oakland, CA, 94605
PHONE:
EMAIL:
BUSINESS HOURS:
Monday – Friday:
8:30am-5:00pm